Axogen (AXGN) Revenue Growth (3y) (2013 - 2026)
Axogen (AXGN) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 0.73% |
| 10 | Axogen | 2.11 Bn | 2.01 Bn | 46.19 Mn | 18.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.79% |
| Dec 31, 2025 | 18.32% |
| Sep 30, 2025 | 17.58% |
| Jun 30, 2025 | 18.04% |
| Mar 31, 2025 | 16.13% |
| Dec 31, 2024 | 16.14% |
| Sep 30, 2024 | 15.95% |
| Jun 30, 2024 | 12.58% |
| Mar 31, 2024 | 10.06% |
| Dec 31, 2023 | 9.72% |
| Sep 30, 2023 | 7.28% |
| Jun 30, 2023 | 19.94% |
| Mar 31, 2023 | 14.76% |
| Dec 31, 2022 | 8.69% |
| Sep 30, 2022 | 8.97% |
| Jun 30, 2022 | 8.87% |
| Mar 31, 2022 | 10.02% |
| Dec 31, 2021 | 10.41% |
| Sep 30, 2021 | 11.25% |
| Jun 30, 2021 | 17.72% |